Sinopharm Tech Holdings Limited, an investment holding company, engages in trading of medical and related products in China and Hong Kong. The company operates through Healthcare Industry and Pharmaceutical Supply Chain Services segments. It is involved in the provision of Internet plus solution services, including provision of internet related solution services; and manufacturing and distribution of personal protective equipment, consumables, and other related goods. The company also engages in providing supply chain services, including provision of supply chain management, data analysis, and related services. Sinopharm Tech Holdings Limited was formerly known as China Vanguard You Champion Holdings Limited and changed its name to Sinopharm Tech Holdings Limited in June 2019. The company was founded in 1999 and is based in Central, Hong Kong.
Research context
Sinopharm Tech Holdings Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Technology
- Industry
- Software - Application
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Sinopharm Tech Holdings Limited is currently in a long term uptrend where the price is trading 7.0% above its 200 day moving average.
From a valuation standpoint, the stock is 128.1% more expensive than other stocks from the Technology sector with a price to sales ratio of 7.9.
Sinopharm Tech Holdings Limited's total revenue sank by 75.2% to $9M since the same quarter in the previous year.
Its net income has increased by 27.5% to $-10M since the same quarter in the previous year.
Finally, its free cash flow fell by 7.6% to $-10M since the same quarter in the previous year.
Based on the above factors, Sinopharm Tech Holdings Limited gets an overall score of 2/5.